<p>Mice (n = 10/group) received tumor cells and were immunized twice with DNA (empty vector pTHkan, HPV-encoding vector plasmids as indicated) when the tumors were clearly palpable and surface tumor sizes were measured over time. Data gives the average tumor sizes at day 0 (day of first immunization) and at day 39 when the experiment was terminated ± SD, respectively. One of two experiment yielding very similar results is shown.</p
<p>Time axis of experimental set up (<i>a</i>). BM-DC (3×10<sup>6</sup>) were injected twice into C5...
<p>(A) Mice were vaccinated 2 times and then injected with tumor cells 2 weeks later. (B) Tumors wer...
<p>(A) Therapeutic schedule. (B) Mice (n = 5) were immunized by hp53 DNA vaccine administered via in...
<p>Ten 6–8 week-old female C57BL/6 mice were divided into 2 groups. One group was primed with pVR16-...
Humanized mice were inoculated intraperitoneally with BJAB cells containing either WT KSHV or the Δv...
<p>A new group of mice treated with R-LM113 or R-115 from d 10 after tumor implantation (same treatm...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>(A) Vaccination schedule. (B) Mice (n = 5) were immunized with various DNA vaccines and challenge...
<p>C57BL/6 mice (n = 8 per group) were thrice immunized and then challenged s.c. with syngeneic EL4 ...
<p>HT-1080 cells transfected with the corresponding plasmid construct were injected into the foot pa...
<p>(A) Electroporated lesions were kept under control and the diameter was recorded weekly. On the d...
<p>5–8 weeks old C57BL/6 mice were challenged with MOSEC tumor cells (1×10<sup>6</sup> cells/mouse)....
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
327-332Human papillomavirus (HPV) plays important role in developing several types of cancer especia...
<p>Time axis of experimental set up (<i>a</i>). BM-DC (3×10<sup>6</sup>) were injected twice into C5...
<p>(A) Mice were vaccinated 2 times and then injected with tumor cells 2 weeks later. (B) Tumors wer...
<p>(A) Therapeutic schedule. (B) Mice (n = 5) were immunized by hp53 DNA vaccine administered via in...
<p>Ten 6–8 week-old female C57BL/6 mice were divided into 2 groups. One group was primed with pVR16-...
Humanized mice were inoculated intraperitoneally with BJAB cells containing either WT KSHV or the Δv...
<p>A new group of mice treated with R-LM113 or R-115 from d 10 after tumor implantation (same treatm...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>(A) Vaccination schedule. (B) Mice (n = 5) were immunized with various DNA vaccines and challenge...
<p>C57BL/6 mice (n = 8 per group) were thrice immunized and then challenged s.c. with syngeneic EL4 ...
<p>HT-1080 cells transfected with the corresponding plasmid construct were injected into the foot pa...
<p>(A) Electroporated lesions were kept under control and the diameter was recorded weekly. On the d...
<p>5–8 weeks old C57BL/6 mice were challenged with MOSEC tumor cells (1×10<sup>6</sup> cells/mouse)....
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
327-332Human papillomavirus (HPV) plays important role in developing several types of cancer especia...
<p>Time axis of experimental set up (<i>a</i>). BM-DC (3×10<sup>6</sup>) were injected twice into C5...
<p>(A) Mice were vaccinated 2 times and then injected with tumor cells 2 weeks later. (B) Tumors wer...
<p>(A) Therapeutic schedule. (B) Mice (n = 5) were immunized by hp53 DNA vaccine administered via in...